company background image
54A logo

Cann Global DB:54A Stock Report

Last Price

€0.013

Market Cap

€5.2m

7D

-3.6%

1Y

-86.5%

Updated

05 Mar, 2022

Data

Company Financials

54A Stock Overview

Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally.

54A fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Cann Global Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cann Global
Historical stock prices
Current Share PriceAU$0.013
52 Week HighAU$0.25
52 Week LowAU$0.011
Beta1.27
11 Month Change-46.00%
3 Month Change8.00%
1 Year Change-86.50%
33 Year Change-97.43%
5 Year Change-89.20%
Change since IPO-99.56%

Recent News & Updates

Recent updates

Shareholder Returns

54ADE PharmaceuticalsDE Market
7D-3.6%-1.8%-1.8%
1Y-86.5%-12.8%13.6%

Return vs Industry: 54A underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.

Return vs Market: 54A underperformed the German Market which returned 5.9% over the past year.

Price Volatility

Is 54A's price volatile compared to industry and market?
54A volatility
54A Average Weekly Movement35.3%
Pharmaceuticals Industry Average Movement7.9%
Market Average Movement5.0%
10% most volatile stocks in DE Market11.5%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 54A's share price has been volatile over the past 3 months.

Volatility Over Time: 54A's weekly volatility has decreased from 192% to 35% over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
2007n/aSholom Feldmanwww.canngloballimited.com

Cann Global Limited operates in medicinal cannabis and hemp food industries in Australia and internationally. The company operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. It grows and cultivates hemp and medical cannabis products; and provides plant-based food and skincare products.

Cann Global Limited Fundamentals Summary

How do Cann Global's earnings and revenue compare to its market cap?
54A fundamental statistics
Market cap€5.23m
Earnings (TTM)-€3.34m
Revenue (TTM)€659.78k

7.9x

P/S Ratio

-1.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
54A income statement (TTM)
RevenueAU$980.09k
Cost of RevenueAU$752.05k
Gross ProfitAU$228.03k
Other ExpensesAU$5.19m
Earnings-AU$4.97m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Mar 07, 2022

Earnings per share (EPS)-0.019
Gross Margin23.27%
Net Profit Margin-506.61%
Debt/Equity Ratio0.7%

How did 54A perform over the long term?

See historical performance and comparison